Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects

NCT04570267 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: CSL324
DRUG: Placebo

Sponsor

CSL Behring